The Editor's Roundtable: Management and Treatment of Non-ST-Segment Elevation in Acute Coronary Syndromes

      This CME activity is supported by an educational grant from GlaxoSmithKline, Brentford, United Kingdom.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Braunwald E.
        • Antman E.M.
        • Beasley J.W.
        • Califf R.M.
        • Cheitlin M.D.
        • Hochman J.S.
        • Jones R.H.
        • Kereiakes D.
        • Kupersmith J.
        • Levin T.N.
        • et al.
        ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction.
        (Accessed July 12, 2007)
        • Bassand J.-P.
        • Hamm C.W.
        • Ardissino D.
        • Boersma E.
        • Budaj A.
        • Fernández-Avilés F.
        • Fox K.A.A.
        • Hasdai D.
        • Ohman E.M.
        • Wallentin L.
        • Wiljns W.
        Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.
        Eur Heart J. 2007; 28: 1598-1660
        • Anderson J.L.
        • Adams C.D.
        • Antman E.M.
        • Bridges C.R.
        • Califf R.M.
        • Casey Jr, D.E.
        • Chavey II, W.E.
        • Fesmire F.M.
        • Hochman J.S.
        • Levin T.N.
        • et al.
        ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction).
        Circulation. 2007; 116: e148-e304
        • Libby P.
        Current concepts of the pathogenesis of the acute coronary syndromes.
        Circulation. 2001; 104: 365-372
        • Wasserman E.J.
        • Shipley N.M.
        Atherothrombosis in acute coronary syndromes: mechanisms, markers, and mediators of vulnerability.
        Mt Sinai J Med. 2006; 73: 431-439
        • Mukherjee D.
        • Bates E.R.
        Current role of antithrombotic agents in the treatment of acute coronary syndrome.
        Semin Thromb Hemost. 2004; 30: 627-632
        • Alexander J.H.
        • Singh K.P.
        Inhibition of factor Xa: a potential target for the development of new anticoagulants.
        Am J Cardiovasc Drugs. 2005; 5: 279-290
        • Bloom A.L.
        Physiology of blood coagulation.
        Haemostasis. 1990; 20: 14-29
        • Arnout J.
        • Hoyaerts M.F.
        • Lijnen H.R.
        Hemostasis.
        Handb Exp Pharmacol. 2006; 176: 1-41
        • Turpie A.G.
        Pharmacology of the low-molecular-weight heparins.
        Am Heart J. 1998; 135: S329-S335
        • Lee S.
        • Gibson C.M.
        Enoxaparin in acute coronary syndrome.
        Expert Rev Cardiovasc Ther. 2007; 5: 387-399
        • Shammas N.W.
        Bivalirudin: pharmacology and clinical applications.
        Cardiovasc Drug Rev. 2005; 23: 345-360
        • Petitou M.
        • Duchaussoy P.
        • Herbert J.M.
        • Duc G.
        • El Hajji M.
        • Branellec J.F.
        • Donat F.
        • Necciari J.
        • Cariou R.
        • Bouthier J.
        • Garrigou E.
        The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa.
        Semin Thromb Hemost. 2002; 28: 393-402
        • Lang R.A.
        • Hillis L.D.
        Antiplatelet therapy for ischemic heart disease.
        N Engl J Med. 2004; 350: 277-280
        • Steinhubl S.R.
        • Moliterno D.J.
        The role of the platelet in the pathogenesis of atherothrombosis.
        Am J Cardiovasc Drugs. 2005; 5: 399-408
        • Savi P.
        • Herbert J.M.
        Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
        Semin Thromb Hemost. 2005; 31: 164-183
        • Vorchheimer D.A.
        • Badimon J.J.
        • Fuster V.
        Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
        JAMA. 1999; 281: 1407-1414
        • Stone G.W.
        • Bertrand M.E.
        • Moses J.W.
        • Ohman E.M.
        • Lincoff A.M.
        • Ware J.H.
        • Pocock S.J.
        • McLaurin B.T.
        • Cox D.A.
        • Jafar M.Z.
        • ACUITY Investigators
        Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
        JAMA. 2007; 297: 591-602
        • Hirsch A.
        • Windhausen F.
        • Tijssen J.G.P.
        • Verheugt F.W.A.
        • Cornel J.H.
        • de Winter R.J.
        • Invasive Versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators
        Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study.
        Lancet. 2007; 369: 827-835
        • The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS 5) Investigators
        Comparison of fondaparinux and enoxaparin in acute coronary syndromes.
        N Engl J Med. 2006; 354: 1464-1476
        • Strauss D.G.
        • Spraque P.Q.
        • Underhill K.
        • Maynard C.
        • Adams G.L.
        • Kessenich A.
        • Sketch M.H.
        • Berger P.B.
        • Marcozzi D.
        • Granger C.B.
        • Wagner G.S.
        Paramedic transtelephonic communication to cardiologist of clinical and electrocardiographic assessment for rapid reperfusion of ST-elevation myocardial infarction.
        J Electrocardiol. 2007; 40: 265-270
        • Pope J.H.
        • Aufderheide T.P.
        • Ruthazer R.
        • Woolard R.H.
        • Feldman J.A.
        • Beshansky J.R.
        • Griffith J.L.
        • Selker H.P.
        Missed diagnoses of acute cardiac ischemia in the emergency department.
        N Engl J Med. 2000; 342: 1163-1170
        • Goldstein J.A.
        • Gallagher M.J.
        • O'Neill W.W.
        • Ross M.A.
        • O'Neil B.J.
        • Raff G.L.
        A randomized controlled trial of multi-slice coronary computer tomography for evaluation of acute chest pain.
        J Am Coll Cardiol. 2007; 49: 863-871
        • Weston P.
        • Alexander J.H.
        • Patel M.R.
        • Maynard C.
        • Crawford L.
        • Wagner G.S.
        Hand-held echocardiographic examination of patients with symptoms of acute coronary syndromes in the emergency department: the 30-day outcome associated with normal left ventricular wall motion.
        Am Heart J. 2004; 148: 1096-1101
        • Douglas P.S.
        • Khandheria B.
        • Stainback R.F.
        • Weissman N.J.
        • Brindis R.G.
        • Patel M.R.
        • Khandheria B.
        • Alpert J.S.
        • Fitzgerald D.
        • Heidenreich P.
        • et al.
        ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography.
        J Am Coll Cardiol. 2007; 52: 187-204
        • Kastrati A.
        • Mehilli J.
        • Schühlen H.
        • Dirschinger J.
        • Dotzer F.
        • ten Berg J.M.
        • Neumann F.J.
        • Bollwein H.
        • Volmer C.
        • Gawaz M.
        • et al.
        Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators.
        N Engl J Med. 2004; 350: 232-238
        • Mehta S.R.
        • Yusuf S.
        • Peters R.J.
        • Bertrand M.E.
        • Lewis B.S.
        • Natarajan M.K.
        • Malmberg K.
        • Rupprecht H.
        • Zhao F.
        • Chrolavicius S.
        • et al.
        • Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial (CURE) Investigators
        Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
        Lancet. 2001; 358: 527-533
        • Kastrati A.
        • Mehilli J.
        • Neumann F.J.
        • Dotzer F.
        • ten Berg J.
        • Bollwein H.
        • Graf I.
        • Ibrahim M.
        • Pache J.
        • Sayfarth M.
        • et al.
        • Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action for Coronary Treatment-2 (ISAR-REACT-2) Trial Investigators
        Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.
        JAMA. 2006; 295: 1531-1538
        • Mehta R.H.
        • Roe M.T.
        • Chen A.Y.
        • Lytle B.L.
        • Pollack C.V.
        • Brindis R.G.
        • Smith S.C.
        • Harrington R.A.
        • Fintel D.
        • Fraulo E.S.
        • et al.
        Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
        Arch Intern Med. 2006; 166: 2027-2034
        • Lewis B.S.
        • Mehta S.R.
        • Fox K.A.
        • Halon D.A.
        • Zhao F.
        • Peters R.J.
        • Keltai M.
        • Budaj A.
        • Yusuf S.
        • CURE Trial Investigators
        Benefit of clopidogrel according to timing of percutaneous coronary intervention in patient with acute coronary syndromes: further results from the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study.
        Am Heart J. 2005; 150: 1177-1184
        • Neumann F.-J.
        • Kastrati A.
        • Pogatsa-Murray G.
        • Mehilli J.
        • Bollwein H.
        • Bestehorn H.-P.
        • Schmitt C.
        • Seyfarth M.
        • Dirschinger J.
        • Schömig A.
        Evaluation of prolonged antithrombotic pretreatment (“cooling-off” strategy) before intervention in patients with unstable coronary syndromes.
        JAMA. 2003; 290: 1593-1599
        • Fox K.A.
        • Poole-Wilson P.
        • Clayton T.C.
        • Henderson R.A.
        • Shaw T.R.
        • Wheatley D.J.
        • Knight R.
        • Pocock S.J.
        5-Year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomized trial.
        Lancet. 2005; 366: 914-920
        • Lagerqvist B.
        • Husted S.
        • Kontny F.
        • Ståhle E.
        • Swahn E.
        • Wallentin L.
        • Fast Revascularization During Instability in Coronary Artery Disease (FRISC-II) Investigators
        5-Year outcomes in the FRISC-II randomized trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study.
        Lancet. 2006; 368: 998-1004
        • Fox K.A.
        • Steg P.G.
        • Eagle K.A.
        • Goodman S.G.
        • Anderson Jr, F.A.
        • Granger C.B.
        • Flather M.D.
        • Budaj A.
        • Quill A.
        • Gore J.M.
        • GRACE Investigators
        Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006.
        JAMA. 2007; 297: 1892-1900
        • Lincoff A.M.
        • Kleiman N.S.
        • Kereiakes D.J.
        • Feit F.
        • Bittl J.A.
        • Jackman J.D.
        • Sarembock I.J.
        • Cohen D.J.
        • Spriggs D.M.
        • Ebrahimi R.
        • et al.
        • REPLACE-2 Investigators
        Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.
        JAMA. 2004; 292: 696-703
        • Rao S.V.
        • Jollis J.G.
        • Harrington R.A.
        • Granger C.B.
        • Newby L.K.
        • Armstrong P.W.
        • Moliterno D.J.
        • Lindblad L.
        • Pieper K.
        • Topol E.J.
        • et al.
        Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.
        JAMA. 2004; 292: 1555-1562
        • Rao S.V.
        • O'Grady K.
        • Pieper K.S.
        • Granger C.B.
        • Newby L.K.
        • Van de Werf F.
        • Mahaffey K.W.
        • Califf R.M.
        • Harrington R.A.
        Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.
        Am J Cardiol. 2005; 96: 1200-1206
      1. Wang TY, Xia L, Alexander KP, Rao SV, Ou F-S, Roe MT, Brindis R, Rumsfeld JS, Peterson ED. Trends in antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding [abstract]. Presented at: AHA Scientific Forum on Quality of Care and Outcomes Research; 2007.

        • Klein W.
        • Kraxner W.
        • Hödl R.
        • Steg P.G.
        • Budaj A.
        • Gulba D.
        • Sadiq I.
        • van de Werf F.
        • White K.
        • Fox K.A.
        • GRACE Investigators
        Patterns of use of heparins in ACS. Correlates and hospital outcomes: the Global Registry of Acute Coronary Events (GRACE).
        Thromb Haemost. 2003; 90: 519-527
      2. Rao SV, Ou FS, Wang TY, Xiao L, Alexander KP, Kosiborod MN, Rumsfeld JS, Spertus JA, Peterson ED. The radial approach to percutaneous coronary intervention is associated with a lower risk for complications regardless of radial procedure volume: a report from the American College of Cardiology National Cardiovascular Data Registry [abstract]. Presented at: American College of Cardiology 2007 Scientific Sessions; New Orleans, Louisiana; March 25, 2007.

        • Tolleson T.R.
        • O'Shea J.C.
        • Bittl J.A.
        • Hillegass W.B.
        • Williams K.A.
        • Levine G.
        • Harrington R.A.
        • Tcheng J.E.
        Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial.
        J Am Coll Cardiol. 2003; 41: 386-393
        • Spertus J.A.
        • Kettelkamp R.
        • Vance C.
        • Decker C.
        • Jones P.G.
        • Rumsfeld J.S.
        • Messenger J.C.
        • Khanal S.
        • Peterson E.D.
        • Bach R.G.
        • Krumholz H.M.
        • Cohen D.J.
        Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.
        Circulation. 2006; 113: 2803-2809
        • Fox K.A.
        • Mehta S.R.
        • Peters R.
        • Zhao F.
        • Lakkis N.
        • Gersh B.J.
        • Yusuf S.
        • Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators
        Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial.
        Circulation. 2004; 110: 1202-1208
        • Singh A.K.
        • Szcech L.
        • Tang K.L.
        • Barnhart H.
        • Sapp S.
        • Wolfson M.
        • Reddan D.
        • CHOIR Investigators
        Correction of anemia with epoetin alfa in chronic kidney disease.
        N Engl J Med. 2006; 355: 2085-2098
        • Phrommintikul A.
        • Haas S.J.
        • Elsik M.
        • Krum H.
        Mortality and target hemoglobin concentrations in anemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
        Lancet. 2007; 369: 381-388
        • American College of Physicians
        Practice strategies for elective red blood cell transfusion.
        Ann Intern Med. 1992; 116: 403-406
        • Welch H.G.
        • Meehan K.R.
        • Goodnough L.T.
        Prudent strategies for elective red blood cell transfusion.
        Ann Intern Med. 1992; 116: 393-402
        • Rioufol G.
        • Finet G.
        • Ginon I.
        • André-Fouët X.
        • Rossi R.
        • Vialle E.
        • Desjoyaux E.
        • Convert G.
        • Huret J.F.
        • Tabib A.
        Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study.
        Circulation. 2002; 106: 804-808
        • Maehara A.
        • Mintz G.S.
        • Bui A.B.
        • Walter O.R.
        • Castagna M.T.
        • Canos D.
        • Pichard A.D.
        • Satler L.F.
        • Waksman R.
        • Suddath W.O.
        • et al.
        Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound.
        J Am Coll Cardiol. 2002; 40: 904-910
        • Bauters C.
        • Lablanche J.M.
        • Renaud N.
        • McFadden E.P.
        • Hamon M.
        • Bertrand M.E.
        Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques.
        Eur Heart J. 1996; 17: 1554-1559
        • Ueda Y.
        • Asakura M.
        • Hirayama A.
        • Komamura K.
        • Hori M.
        • Kodama K.
        Intracoronary morphology of culprit lesions after reperfusion in acute myocardial infarction: serial angioscopic observations.
        J Am Coll Cardiol. 1996; 27: 606-610
        • Fonarow G.C.
        • Heywood J.T.
        • Heidenreich P.A.
        • Lopatin M.
        • Yancy C.W.
        • ADHERE Scientific Advisory Committee and Investigators
        Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE).
        Am Heart J. 2007; 153: 1021-1028